Ophir Shahaf
Direktor/Vorstandsmitglied bei MERCHAVIA HOLDINGS AND INVESTMENTS LTD
Profil
Ophir Shahaf is currently a Director at Merchavia Holdings & Investments Ltd.
since 2019 and a Partner at eHealth Ventures Israel Ltd.
since 2015.
Previously, he served as the Chief Executive Officer at HBL- Hadasit Bio-Holdings Ltd.
and Hadasit Bio-Holdings Ltd.
from 2007 to 2013.
He also held positions as a Director at Thrombotech Ltd., KAHR Medical Ltd., Bio-MarCare Technologies Ltd., Vice President & General Counsel at Clal Biotechnology Industries Ltd., and Vice President-Business Development at Protalix Biotherapeutics Ltd.
Mr. Shahaf holds an MBA from New York University, a graduate degree from Tel-Aviv University, and an MBA from The Leonard N Stern School of Business.
Aktive Positionen von Ophir Shahaf
Unternehmen | Position | Beginn |
---|---|---|
MERCHAVIA HOLDINGS AND INVESTMENTS LTD | Direktor/Vorstandsmitglied | 14.03.2019 |
Ehealth Ventures Israel Ltd.
Ehealth Ventures Israel Ltd. Investment ManagersFinance Ehealth Ventures Israel Ltd (eHealth Ventures) is a venture capital firm founded in 2014 by Stephen Shapiro. The firm is headquartered in Tel Aviv, Israel. | Private Equity Investor | 01.11.2015 |
Ehemalige bekannte Positionen von Ophir Shahaf
Unternehmen | Position | Ende |
---|---|---|
Hadasit Bio-Holdings Ltd. /Private Equity/
Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings Ltd. /Private Equity/ (Hadasit Bio-Holdings /Private Equity/) is a private equity division of Hadasit Bio-Holdings Ltd. founded in 2005. The firm is headquartered in Jerusalem, Israel. | Vorstandsvorsitzender | 31.12.2013 |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Direktor/Vorstandsmitglied | - |
Bio-MarCare Technologies Ltd.
Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | 02.01.1901 |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - |
CLAL BIOTECHNOLOGY INDUSTRIES LTD. | General Counsel | - |
Ausbildung von Ophir Shahaf
Tel-Aviv University | Graduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
HBL - HADASIT BIO-HOLDINGS LTD | Finance |
CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
MERCHAVIA HOLDINGS AND INVESTMENTS LTD | Finance |
Private Unternehmen | 6 |
---|---|
Hadasit Bio-Holdings Ltd. /Private Equity/
Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings Ltd. /Private Equity/ (Hadasit Bio-Holdings /Private Equity/) is a private equity division of Hadasit Bio-Holdings Ltd. founded in 2005. The firm is headquartered in Jerusalem, Israel. | Finance |
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The private company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Bio-MarCare Technologies Ltd.
Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel. | Health Services |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
Ehealth Ventures Israel Ltd.
Ehealth Ventures Israel Ltd. Investment ManagersFinance Ehealth Ventures Israel Ltd (eHealth Ventures) is a venture capital firm founded in 2014 by Stephen Shapiro. The firm is headquartered in Tel Aviv, Israel. | Finance |